claretierney

31 POSTS 0 COMMENTS

Non-optimal therapy for CLTI “more prominent in females”

lena makowski
A real-world claims data analysis of nearly 200,000 patients with chronic limb-threatening ischaemia (CLTI) showed that female patients were older, underwent vascular procedures less...

CATHI joins with VSS to launch world’s first online training programme...

cathi
Germany-based endovascular simulator supplier CATHI has joined forces with UK-based Vascular Simulation Solutions (VSS) to offer the world’s first online training masterclass using endovascular...

CLS Americas debuts fusion-guided TRANBERG focal laser ablation system at AUA...

cls
CLS Americas announced it will debut its office-based, magnetic resonance (MR)/ultrasound (US) fusion-guided, TRANBERG Thermal Therapy System for high-precision focal laser ablation of soft...

Interventional Systems announces strategic collaboration agreement with the Johns Hopkins University’s...

interventional systems
Interventional Systems recently announced a new collaboration with Johns Hopkins University (Baltimore, USA) in a company press release. The research team at Johns Hopkins,...

Interventional News’ top 10 most read articles of April 2022

TOP 10
A report from the American Venous Forum (AVF) 2022 meeting (23–26 February, Orlando, USA) on the comparative merits and demerits of dedicated and non-dedicated...

First patient enrolled in PERIO-02 trial of SD-101 delivery via pressure-enabled...

trisalus
TriSalus Life Sciences announced the enrolment of the first patient in its Pressure-Enabled Regional Immuno-Oncology (PERIO-02) clinical study in a press release.  The trial is...

Magneto Thrombectomy Solutions announces successful first-in-human results for treatment of pulmonary...

magneto
Magneto Thrombectomy Solutions (Magneto), a medical devices company developing thrombectomy solutions for the treatment of ischaemic stroke and pulmonary embolism, presented successful first-in-human (FIH)...

Micromate now available to use with CT guidance thanks to planning...

micromate
The new addition to Micromate makes it possible for physicians to rely on pre- and intraoperative scans to plan the intervention, the company behind...

STAR network to collaborate with Avail surgical telepresence platform to enhance...

star
Avail Medsystems, a healthcare technology company whose surgical telepresence platform facilitates real-time, interactive collaboration during live procedures among a network of physicians and medical...

Boston Scientific Receives FDA Clearance for the EMBOLD Fibered Detachable Coil

embold
Boston Scientific has received US Food and Drug Administration (FDA) 510(k) clearance for the EMBOLD Fibered Detachable Coil, which is indicated to obstruct or...

IN.PACT AV drug-coated balloon first and only to show sustained and...

inpact av
Medtronic announced new randomised controlled data demonstrating the sustained and superior performance of IN.PACT AV drug-coated balloon (DCB) compared to percutaneous transluminal angioplasty (PTA)...

Five-year data presented at Charing Cross reinforce safety of Passeo-18 Lux...

biotronik data
New long-term data presented at Charing Cross (CX) demonstrated the safety of BIOTRONIK’s Passeo-18 Lux paclitaxel drug-coated balloon (DCB) for the treatment of peripheral...

Profligacy and dangerous misconceptions in dialysis access

Scott Trerotola (University of Pennsylvania, Philadelphia, USA), who will be awarded a Society of Interventional Radiology (SIR) Gold Medal in June 2022, raises some...

EDDA Technology announces trial agreement with SIO

EDDA Technology, a provider of advanced imaging-guided precision treatment solutions, announced it has entered into an agreement with the Society of Interventional Oncology (SIO)...

Cydar Medical announces strategic collaboration with Medtronic

Cydar Medical recently announced it has entered a strategic collaboration with Medtronic. Under the pilot arrangement, Cydar’s EV Maps software will be introduced to...

Karim Valji

valji
“I took a giant leap of faith and applied for a radiology residency with the sole intention of doing interventional radiology (IR). I was...

Interventional News’ top 10 most popular items of March 2022

TOP 10
The March top 10 features news that the US trial of the LimFlow system designed to prevent amputations has completed enrolment. Other highlights include two...

SIO 2022: ‘Controversies’ in current cancer treatment

One of the sessions at this year’s Society of Interventional Oncology (SIO) meeting (24–28 March, San Francisco, USA) comprised four debates moderated by David...

Alucent Biomedical announces first patient enrolled in first-in-human natural vascular scaffolding...

alucent
Alucent Biomedical announced in a press release that it has enrolled the first patient in ACTIVATE II, an Australia-based first-in-human clinical trial to evaluate...

Interventional News Issue 85—April 2022 US Edition

in85
Interventional News 85 Highlights: Profligacy and dangerous misconceptions in dialysis access SIO 2022: 'Controversies' in current cancer treatment Promoting equality in interventional radiology "Dramatic...

Interventional News Issue 85—April 2022 Edition

in85
Interventional News 85 Highlights: Profligacy and dangerous misconceptions in dialysis access SIO 2022: 'Controversies' in current cancer treatment Promoting equality in interventional radiology "Dramatic...

Truvic announces US FDA 510(k) clearance for Prodigy thrombectomy system

truvic766x512
Truvic Medical, a subsidiary of Imperative Care, announced in a press release that it has received 510(k) clearance from the US Food and Drug...

Data from new VOYAGER PAD reinforce benefit of XARELTO (rivaroxaban) plus...

An analysis showed benefit of XARELTO plus aspirin in reducing thrombotic hospitalisations for peripheral arterial disease (PAD) patients with and without chronic kidney disease...

CX 2022: A conversation with Robert Hinchliffe 

hinchliffe
Robert Hinchliffe (University of Bristol, Bristol, UK) shares his excitement to attend the upcoming CX Symposium (26–28 April, London, UK). “CX has always represented...

Tractus Vascular announces first-in-man use of Tractus Crossing Support Catheter with...

tractus
Tractus Vascular recently announced the first-in-man use of the Tractus Crossing Support Catheter (Tractus CSC). The Tractus CSC represents a highly novel approach to...

Interventional News’ top 10 most popular items of February 2022

February's
The February top 10 features news of the recent Japanese randomised control trial results, which support the use of mechanical thrombectomy in ischaemic stroke...

Instylla first-in-human clinical trial published results demonstrate success

instylla
A prospective multicentre study has evaluated the safety and efficacy of a polyethylene glycol (PEG)-based liquid embolic in treating hypervascular tumours, according to an...

Merit Medical wins FDA breakthrough nod for microspheres for treating knee...

Merit Medical FDA breakthrough
Merit Medical announced today that it has received US Food and Drug Administration (FDA) breakthrough device designation for its Embosphere microspheres. Utah-based Merit Medical’s breakthrough...

Metastatic tumour treatment with novel GPX embolic device

embolic device
An embolic device by Fluidx Medical has been used successfully in a variety of complex cancer cases, according to a company press release. As part...

Guerbet expands portfolio with microcatheters and guidewires for interventional imaging and...

Guerbet
Guerbet announces it will more than double its line of microcatheters and launch a new line of guidewires, resulting in a broad range of...

Wesley Medical Imaging becomes first hospital in Australia to achieve IASIOS...

wesley
Ten centres have achieved the International Accreditation System for Interventional Oncology Services (IASIOS) accreditation, a benchmark of quality standard and assurance, since 2018. Wesley...